UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in XNCR — Xencor Inc
CIK 861177
NEW YORK, NY
Position in XNCR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,151,712
+$4,688,330 QoQ
Shares Held
382,094
+214.9% QoQ
Ownership
0.514%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 208 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in XNCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. XNCR ranks #52 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in XNCR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,151,712 | 382,094 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,463,382 | 121,342 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,833,967 | 119,789 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,948,843 | 166,142 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,645,686 | 209,375 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,916,260 | 180,100 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $7,383,654 | 321,308 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,694,132 | 332,876 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,433,470 | 339,856 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,968,302 | 269,693 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $5,718,128 | 269,342 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $5,481,865 | 272,053 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $6,688,535 | 267,863 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $7,470,695 | 267,863 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $6,964,812 | 267,466 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $6,497,413 | 250,093 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,780,340 | 247,729 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $7,084,336 | 265,530 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $10,789,509 | 268,931 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,997,827 | 275,500 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,719,140 | 281,796 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $9,535,977 | 221,458 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $9,781,449 | 224,191 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $9,138,339 | 235,585 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $7,392,205 | 228,225 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $6,449,146 | 215,835 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||